An observational study in Chronic Urticaria, sponsored by Zealand University Hospital. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Zealand University Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Chronic urticaria (CU) is a dermatological condition characterized by recurrent itchy wheals and/or angioedema persisting for more than six weeks. Despite affecting approximately 1% of the global population, the pathophysiological mechanisms underlying CU remain poorly understood, and current treatment options are limited. We will investigate the proteome of CU by analyzing skin biopsies from patients using mass spectrometry-based proteomics. This approach will enhance our understanding of CU at the molecular level, potentially leading to improved diagnostic tools and more effective targeted therapies, ultimately improving the quality of life for patients suffering from this debilitating condition.
197 studies on the registry are indexed under Chronic Urticaria; 48 are open to participants now.
This study's planned enrollment of 80 is below the median of 165 across 40 observational studies indexed under Chronic Urticaria.
Browse Chronic Urticaria studies →Zealand University Hospital is the lead sponsor of 237 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients will be recruited from the Dept. of Dermatology and Allergy at Herlev and Gentofte Hospital, the Dept. of Dermatology at Zealand University Hospital, as well as through advertising in Denmark.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with chronic urticaria.
Procedure: Punch biopsy
Age-, sex- and site-matched healthy controls.
Procedure: Punch biopsy
Skin punch biopsy.
Proteomic characterisation
Description of proteomic signatures, as measured by mass spectrometry
Time frame: Data collection and analysis between late 2026 and late 2029
No study locations are listed for this record.
Plan to share: No — Individual participant data will not be shared in compliance with Danish legislation and The Research Ethics Committee for Region Zealand (Den Videnskabsetiske Komité for Region Sjælland).
Start is estimated for Dec 2026; primary completion for Dec 2028, 24 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.